Kezdőlap › Akut mieloid leukémia › Pennsylvania › Pittsburgh
Akut mieloid leukémia klinikai vizsgálatok: Pittsburgh, PA
18 Akut mieloid leukémia vizsgálat keres résztvevőket Pittsburgh és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Toborzás folyamatban2. fázis
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Toborzás folyamatban1. fázis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- UPMC Hillman Cancer Center, Pittsburgh
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Toborzás folyamatban3. fázis
- University of Pittsburgh Medical Center, Pittsburgh
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- UPMC Hillman Cancer Center, Pittsburgh
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- UPMC Hillman Cancer Center, Pittsburgh
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Toborzás folyamatban3. fázis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Study of BGB-11417 in Participants With Myeloid Malignancies
Toborzás folyamatban1/2. fázis
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Toborzás folyamatban3. fázis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Toborzás folyamatban3. fázis
- US-Pittsburgh PA-PITT, Pittsburgh
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Toborzás folyamatban3. fázis
- US-Pittsburgh PA-PITT, Pittsburgh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Toborzás folyamatban1/2. fázis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Toborzás folyamatban1. fázis
- UMPC Hillman Cancer Center, Pittsburgh
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
Toborzás folyamatban2. fázis
- UPMC Hillman Cancer Center, Pittsburgh
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Toborzás folyamatbanMegfigyeléses tanulmány
- Children's Hospital of Pittsburgh, Pittsburgh
- West Penn Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- és további 1
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Toborzás folyamatban1/2. fázis
- Allegheny Health Network, Pittsburgh
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Toborzás folyamatban2. fázis
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Akut mieloid leukémia vizsgálatok más városokban
- Houston, TX85 tanulmány
- New York City, NY51 tanulmány
- Boston, MA44 tanulmány
- Seattle, WA41 tanulmány
- Baldwin Park, CA40 tanulmány
- Columbus, OH35 tanulmány
- Philadelphia, PA34 tanulmány
- Durham, NC33 tanulmány
- Atlanta, GA31 tanulmány
- Tampa, FL29 tanulmány
- Chicago, IL26 tanulmány
- Portland, OR25 tanulmány
Egyéb vizsgálatok: Pittsburgh
- Nem kis sejtes tüdőrák48 tanulmány
- Rák (minden típus)41 tanulmány
- Mellrák39 tanulmány
- Kolorektális rák32 tanulmány
- Áttétes rák31 tanulmány
- Melanóma31 tanulmány
- Petefészekrák30 tanulmány
- Endometriális rák23 tanulmány
- Prosztatarák23 tanulmány
- Tüdőrák23 tanulmány
- Fej- és nyaki laphámrák22 tanulmány
- Sztrók22 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.